Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Foster

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
Journal of the American Chemical Society|February 22, 2025
Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes DrugAlexander I P Taylor, Yong Xu, Martin Wilkinson, et al.
Cardiovascular and Interventional Radiology|March 20, 2002
Percutaneous imaging-guided access for the treatment of calculi in continent urinary reservoirsWinston Brooks Davis, Scott O Trerotola, Matthew S Johnson, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channelToshana L Foster, Mark Verow, Ann L Wozniak, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 16, 2014
Modelling concentration-analgesia relationships for morphine to evaluate experimental pain modelsEva Sverrisdóttir, David John Richard Foster, Richard Neil Upton, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
A Comparative Assessment Study of Known Small-molecule GPVI ModulatorsHolly Foster, Clare Wilson, Julia S Gauer, et al.
Journal of Virology|February 24, 2012
High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitorsLaura F Wetherill, Kristopher K Holmes, Mark Verow, et al.
Scientific Reports|December 7, 2017
Na<sup>+</sup> entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cellsKatsuhiko Muraki, Kaori Ohnishi, Akiho Takezawa, et al.
Plos One|January 23, 2024
Side-by-side comparison of published small molecule inhibitors against thapsigargin-induced store-operated Ca2+ entry in HEK293 cellsKatherine Norman, Karen E Hemmings, Heba Shawer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2021
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XIKatherine J Kearney, Juliet Butler, Olga M Posada, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal of the American Chemical Society|February 22, 2025
Kinetic Steering of Amyloid Formation and Polymorphism by Canagliflozin, a Type-2 Diabetes DrugAlexander I P Taylor, Yong Xu, Martin Wilkinson, et al.
Cardiovascular and Interventional Radiology|March 20, 2002
Percutaneous imaging-guided access for the treatment of calculi in continent urinary reservoirsWinston Brooks Davis, Scott O Trerotola, Matthew S Johnson, et al.
Frontiers in Pharmacology|March 15, 2021
The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis <i>In Vitro</i> and Induces Vasodilatation Without Desensitisation <i>In Vivo</i>Cai Read, Duuamene Nyimanu, Peiran Yang, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Resistance mutations define specific antiviral effects for inhibitors of the hepatitis C virus p7 ion channelToshana L Foster, Mark Verow, Ann L Wozniak, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 16, 2014
Modelling concentration-analgesia relationships for morphine to evaluate experimental pain modelsEva Sverrisdóttir, David John Richard Foster, Richard Neil Upton, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
A Comparative Assessment Study of Known Small-molecule GPVI ModulatorsHolly Foster, Clare Wilson, Julia S Gauer, et al.
Journal of Virology|February 24, 2012
High-risk human papillomavirus E5 oncoprotein displays channel-forming activity sensitive to small-molecule inhibitorsLaura F Wetherill, Kristopher K Holmes, Mark Verow, et al.
Scientific Reports|December 7, 2017
Na<sup>+</sup> entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cellsKatsuhiko Muraki, Kaori Ohnishi, Akiho Takezawa, et al.
Plos One|January 23, 2024
Side-by-side comparison of published small molecule inhibitors against thapsigargin-induced store-operated Ca2+ entry in HEK293 cellsKatherine Norman, Karen E Hemmings, Heba Shawer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2021
Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XIKatherine J Kearney, Juliet Butler, Olga M Posada, et al.
Pageof 11